Helicore Biopharma
Helicore Bio — Long-Acting Medicines to Transform Metabolic Health
South San Francisco, United States · $65.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- helicore.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series AJan 2025
- Rounds
- 1
About
Clinical-stage biopharmaceutical company developing innovative therapeutics to address obesity and related metabolic diseases.
Summary
Helicore Biopharma is a Biotech company based in South San Francisco, United States. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Jan 2025. Investors include Versant Ventures, OrbiMed and Longitude Capital.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/helicore-biopharma"><img src="https://indexed.vc/api/badge/company/helicore-biopharma" alt="Helicore Biopharma on Indexed.vc" width="260" height="76" /></a>